MEDS 8-K: Shelf registration
DataMEDS AI, Inc.
Filed with the SEC on · accession 0001493152-26-051924
MEDS filed a 8-K (current report) with the SEC on Nov 16, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -13.7% by the first close after the filing.
Summary of the filing
DataMEDS AI, Inc. entered into an at-the-market (ATM) sales agreement with Dawson James Securities, Inc., allowing the company to sell shares of its common stock from time to time through the sales agent under its existing shelf registration statement.
Key details
How MEDS stock reacted
Close before
$0.74
Nov 13, 2026
First close after
-13.68%
$0.64
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for MEDS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MEDS?
Click hereFrequently asked questions
What did MEDS file with the SEC on Nov 16, 2026?
MEDS filed a 8-K (Shelf registration). DataMEDS AI, Inc. entered into an at-the-market (ATM) sales agreement with Dawson James Securities, Inc., allowing the company to sell shares of its common stock from time to time through the sales agent under its existing shelf registration statement.
What does a shelf registration mean for MEDS stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did MEDS stock react to this filing?
MEDS closed at $0.74 before the filing and $0.64 on Nov 16, 2026 (-13.68%).
Other MEDS SEC filings
- 424B5 · Shelf registrationNov 16, 2026
- 10-Q · SEC filingNov 13, 2026
- 8-K · SEC filingNov 13, 2026
- S-1 · Shelf registrationNov 10, 2026
- SCHEDULE 13G · SEC filingNov 10, 2026
- 8-K · SEC filingNov 5, 2026
- 8-K · Material agreementOct 26, 2026
- 8-K · Delisting noticeOct 20, 2026
- 8-K · Material agreementOct 16, 2026
- 8-K · Legal settlementOct 13, 2026
Get alerts when MEDS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days